Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy
氧化应激在福克斯内皮性角膜营养不良发病机制中的作用
基本信息
- 批准号:8957350
- 负责人:
- 金额:$ 50.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAgonistAntioxidantsApoptosisBase Excision RepairsBiogenesisBlindnessCell AgingCell DeathCell LineCell NucleusCellsChronicCorneaCorneal EndotheliumCorneal dystrophyCorneal edemaDNA AdductionDNA AdductsDNA DamageDNA RepairDataDepositionDescemet&aposs membraneDevelopmentDiseaseElderlyEndothelial CellsEndotheliumEnzymesEstrogen MetabolismEstrogensEtiologyExtracellular MatrixFemaleGrantHumanIn VitroIncidenceInvestigationIon PumpsKeratoplastyKnockout MiceLaboratoriesLeadLesionLightLinkMesenchymalMitochondriaMitochondrial DNAModelingMorphologyMusNADPNF-E2-related factor 2NuclearOxidantsOxidative StressPathogenesisPathway interactionsPatientsPredispositionProcessPumpQuinonesRoleSeveritiesSignal PathwayTelomeraseTissuesUVA inducedWomanage relatedbasecytotoxicenzyme pathwaygenotoxicityhuman old age (65+)in vivoirradiationmalemitochondrial dysfunctionoxidative DNA damagepreventpublic health relevancerepairedresponseultraviolet
项目摘要
DESCRIPTION (provided by applicant): Fuchs Endothelial Corneal Dystrophy (FECD), a common age-related dystrophy, which is more prevalent in women, is of unknown etiology. In FECD, corneal endothelial (CE) cell loss is accompanied by abnormal extracellular matrix (ECM) deposition in the form of guttae. Our laboratory was the first to link oxidative stress with FECD pathogenesis. Specifically, we showed that in FECD, oxidant-antioxidant imbalance due to suboptimal Nrf2-regulated antioxidant defense, including a decline in its transcriptional target
NQO1, leads to oxidative DNA damage, mitochondrial dysfunction, and apoptosis. However, little is known regarding the mechanism of guttae formation and the predominance of FECD development in women. The mechanism of the observed DNA damage in cellular degeneration in FECD is not known. Building upon our previous findings, we propose to investigate if oxidant-antioxidant imbalance in FECD leads to endothelial mesenchymal transition (EMT) with concomitant ECM deposition, and if this imbalance causes the formation of cytotoxic estrogen metabolites, which are known to accumulate in tissues with the defective Nrf2-NQO1 and cause DNA damage, more commonly in women. Since our preliminary studies indicate a defective DNA damage response (DDR) in FECD, we will determine whether it leads to decreased DNA damage repair, cellular senescence, and apoptosis. Our proposal seeks to explore three different disease mechanisms: EMT, estrogen genotoxicity, and DDR, all of which either independently or collectively may lead to the development of FECD. Our study is significant, as the investigation of the mechanisms involved in the oxidative stress-induced cellular damage will provide new treatment targets for FECD. In order to achieve these aims, we will use our newly developed telomerase-immortalized human CE cells and the in vivo oxidative stress model based on the ultraviolet-A irradiation of mouse corneas. This model is specifically relevant to our study since it replicates in mice the CE morphological changes with guttae-like lesions and apoptosis, characteristically seen in FECD patients. Our Specific Aims are: Aim 1: Determine whether oxidant-antioxidant imbalance seen in FECD activates EMT that leads to aberrant ECM deposition seen in guttae. This aim is based on the hypothesis that in FECD chronic oxidative stress causes endothelial cells to undergo EMT and enhanced ECM deposition leading to guttae formation that can be modified by activation of Nrf2 pathway. Aim 2: Investigate the role of reactive estrogen metabolites in initiating an estrogen genotoxic pathway that may account for higher incidence and severity of FECD in women. This aim is based on the hypothesis that altered levels of estrogen-metabolizing enzymes lead to imbalanced estrogen metabolism and increased formation of depurinating estrogen-DNA adducts in FECD. Aim 3: Investigate the role of DDR on mitochondrial and nuclear DNA repair during oxidative stress- induced damage of CE in FECD. This aim is based on the hypothesis that impaired DDR leads to deficient DNA repair that results in mitochondrial dysfunction, cellular senescence, and apoptosis.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ula V. Jurkunas其他文献
Outcomes of Boston Keratoprosthesis Type I Implantation in Poland: A Retrospective Study on 118 Patients
波兰 I 型波士顿人工角膜植入术的结果:对 118 名患者进行的回顾性研究
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:3.9
- 作者:
E. Wróblewska;D. Dobrowolski;A. Wylęgała;Ula V. Jurkunas;Edward Wylęgała - 通讯作者:
Edward Wylęgała
The Neuropeptide α-Melanocyte–Stimulating Hormone Prevents Persistent Corneal Edema following Injury
神经肽α-促黑素细胞激素可预防损伤后持续性角膜水肿
- DOI:
10.1016/j.ajpath.2023.09.007 - 发表时间:
2024-01-01 - 期刊:
- 影响因子:3.600
- 作者:
Hamid Alemi;Shudan Wang;Tomas Blanco;Francesca Kahale;Rohan B. Singh;Gustavo Ortiz;Aytan Musayeva;Erdem Yuksel;Kunpeng Pang;Neha Deshpande;Thomas H. Dohlman;Ula V. Jurkunas;Jia Yin;Reza Dana - 通讯作者:
Reza Dana
Ocular Chemical Injuries and Limbal Stem Cell Deficiency (LSCD): An Update on Management.
眼部化学损伤和角膜缘干细胞缺乏症 (LSCD):管理更新。
- DOI:
10.1097/iio.0000000000000487 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Yandong Bian;Ula V. Jurkunas - 通讯作者:
Ula V. Jurkunas
Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal stem cell deficiency: a phase I/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the US
自体培养角膜缘上皮细胞(CALEC)移植治疗角膜缘干细胞缺乏症:美国首次开发的无异种生物、无血清、无抗生素生产方案的 I/II 期临床试验
- DOI:
10.1038/s41467-025-56461-1 - 发表时间:
2025-03-04 - 期刊:
- 影响因子:15.700
- 作者:
Ula V. Jurkunas;Aaron R. Kaufman;Jia Yin;Allison Ayala;Maureen Maguire;Lassana Samarakoon;Lynette K. Johns;Mohit Parekh;Sanming Li;Alex Gauthier;Helene Negre;Kit L. Shaw;Diego E. Hernandez Rodriguez;Heather Daley;Reza Dana;Myriam Armant;Jerome Ritz - 通讯作者:
Jerome Ritz
DMEK surgical training: An instructional guide on various wet-lab methods
DMEK 手术培训:关于各种湿实验室方法的教学指南
- DOI:
10.1016/j.survophthal.2023.06.008 - 发表时间:
2023-11-01 - 期刊:
- 影响因子:5.900
- 作者:
Mohit Parekh;Alessandro Ruzza;Marco Rovati;Argyrios Tzamalis;Davide Romano;Nidhi Gupta;Pravin Vaddavalli;Maninder Bhogal;Vishal Jhanji;Onkar Sawant;Francesco Semeraro;Diego Ponzin;Soosan Jacob;Diana Carmen Dragnea;Marina Rodriguez-Calvo-de-Mora;Sorcha Ní Dhubhghaill;Rajesh Fogla;Namrata Sharma;Ula V. Jurkunas;Stefano Ferrari;Vito Romano - 通讯作者:
Vito Romano
Ula V. Jurkunas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ula V. Jurkunas', 18)}}的其他基金
The Role of Oxidative Stress in the Pathogenesis of Fuchs Endothelial Corneal Dys
氧化应激在福克斯内皮角膜病变发病机制中的作用
- 批准号:
8474767 - 财政年份:2010
- 资助金额:
$ 50.84万 - 项目类别:
Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy
氧化应激在福克斯内皮性角膜营养不良发病机制中的作用
- 批准号:
10667428 - 财政年份:2010
- 资助金额:
$ 50.84万 - 项目类别:
The Role of Oxidative Stress in the Pathogenesis of Fuchs Endothelial Corneal Dys
氧化应激在福克斯内皮角膜病变发病机制中的作用
- 批准号:
7861936 - 财政年份:2010
- 资助金额:
$ 50.84万 - 项目类别:
Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy
氧化应激在福克斯内皮性角膜营养不良发病机制中的作用
- 批准号:
9319755 - 财政年份:2010
- 资助金额:
$ 50.84万 - 项目类别:
The Role of Oxidative Stress in the Pathogenesis of Fuchs Endothelial Corneal Dys
氧化应激在福克斯内皮角膜病变发病机制中的作用
- 批准号:
8689041 - 财政年份:2010
- 资助金额:
$ 50.84万 - 项目类别:
The Role of Oxidative Stress in the Pathogenesis of Fuchs Endothelial Corneal Dys
氧化应激在福克斯内皮角膜病变发病机制中的作用
- 批准号:
8288203 - 财政年份:2010
- 资助金额:
$ 50.84万 - 项目类别:
Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy
氧化应激在福克斯内皮性角膜营养不良发病机制中的作用
- 批准号:
10203989 - 财政年份:2010
- 资助金额:
$ 50.84万 - 项目类别:
Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy
氧化应激在福克斯内皮性角膜营养不良发病机制中的作用
- 批准号:
10448283 - 财政年份:2010
- 资助金额:
$ 50.84万 - 项目类别:
Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy
氧化应激在福克斯内皮性角膜营养不良发病机制中的作用
- 批准号:
10591213 - 财政年份:2010
- 资助金额:
$ 50.84万 - 项目类别:
The Role of Oxidative Stress in the Pathogenesis of Fuchs Endothelial Corneal Dys
氧化应激在福克斯内皮角膜病变发病机制中的作用
- 批准号:
8088101 - 财政年份:2010
- 资助金额:
$ 50.84万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 50.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 50.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别: